You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Dow
Mallinckrodt
Colorcon
Baxter

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Patent: 10,053,489

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,053,489
Title:Method for purifying antibody
Abstract: The present invention relates to a method of purifying an antibody with high purity and high quality by removing impurities by sequential use of a cation-exchange column, a culture supernatant multilayer filter and an anion-exchange column without using a protein-A column that is an affinity chromatography column which is generally used for antibody purification.
Inventor(s): Kim; Soo Kwang (Daejeon, KR), Ahn; Yong Ho (Daejeon, KR), Kim; Young Min (Gyeonggi-do, KR), Song; Dae Hae (Daejeon, KR)
Assignee: Prestige Biopharma PTE, LTD (SG)
Application Number:14/896,380
Patent Claims:see list of patent claims

Details for Patent 10,053,489

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial Prestige Biopharma PTE, LTD (SG) 2033-06-05 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial Prestige Biopharma PTE, LTD (SG) 2033-06-05 RX Orphan search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31   Start Trial Prestige Biopharma PTE, LTD (SG) 2033-06-05 RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31   Start Trial Prestige Biopharma PTE, LTD (SG) 2033-06-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Medtronic
Baxter
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.